Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387305236> ?p ?o ?g. }
- W4387305236 abstract "Background: Osteoporosis is a prevalent bone metabolism disease characterized by a reduction in bone density, leading to several complications that significantly affect patients’ quality of life. The Achyranthes bidentata–Dipsacus asper (AB–DA) herb pair is commonly used in Traditional Chinese Medicine (TCM) to treat osteoporosis. This study aimed to investigate the therapeutic compounds and potential mechanisms of AB–DA using network pharmacology, molecular docking, molecular dynamics simulation, and experimental verification. Methods: Identified compounds of AB–DA were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Traditional Chinese Medicine Information Database (TCM-ID), TCM@Taiwan Database, BATMAN-TCM, and relevant literature. The main bioactive ingredients were screened based on the criteria of “OB (oral bioavailability) ≥ 30, DL (drug-likeness) ≥ 0.18.” Potential targets were predicted using the PharmMapper and SwissTargetPrediction websites, while disease (osteoporosis)-related targets were obtained from the GeneCards, DisGeNET, and OMIM databases. The PPI network and KEGG/GO enrichment analysis were utilized for core targets and pathway screening in the STRING and Metascape databases, respectively. A drug–compound–target–pathway–disease network was constructed using Cytoscape software to display core regulatory mechanisms. Molecular docking and dynamics simulation techniques explored the binding reliability and stability between core compounds and targets. In vitro and in vivo validation experiments were utilized to explore the anti-osteoporosis efficiency and mechanism of sitogluside. Results: A total of 31 compounds with 83 potential targets for AB–DA against osteoporosis were obtained. The PPI analysis revealed several hub targets, including AKT1, CASP3, EGFR, IGF1, MAPK1, MAPK8, and MAPK14. GO/KEGG analysis indicated that the MAPK cascade (ERK/JNK/p38) is the main pathway involved in treating osteoporosis. The D–C–T–P–T network demonstrated therapeutic compounds that mainly consisted of iridoids, steroids, and flavonoids, such as sitogluside, loganic acid, and β-ecdysterone. Molecular docking and dynamics simulation analyses confirmed strong binding affinity and stability between core compounds and targets. Additionally, the validation experiments showed preliminary evidence of antiosteoporosis effects. Conclusion: This study identified iridoids, steroids, and flavonoids as the main therapeutic compounds of AB–DA in treating osteoporosis. The underlying mechanisms may involve targeting core MAPK cascade (ERK/JNK/p38) targets, such as MAPK1, MAPK8, and MAPK14. In vivo experiments preliminarily validated the anti-osteoporosis effect of sitogluside. Further in-depth experimental studies are required to validate the therapeutic value of AB–DA for treating osteoporosis in clinical practice." @default.
- W4387305236 created "2023-10-04" @default.
- W4387305236 creator A5016184474 @default.
- W4387305236 creator A5041477172 @default.
- W4387305236 creator A5082340386 @default.
- W4387305236 creator A5087268228 @default.
- W4387305236 creator A5089217713 @default.
- W4387305236 creator A5091020799 @default.
- W4387305236 date "2023-10-02" @default.
- W4387305236 modified "2023-10-16" @default.
- W4387305236 title "Unraveling the potential mechanisms of the anti-osteoporotic effects of the Achyranthes bidentata–Dipsacus asper herb pair: a network pharmacology and experimental study" @default.
- W4387305236 cites W175660244 @default.
- W4387305236 cites W1970052575 @default.
- W4387305236 cites W1971887776 @default.
- W4387305236 cites W2000163726 @default.
- W4387305236 cites W2002900955 @default.
- W4387305236 cites W2035346822 @default.
- W4387305236 cites W2041564990 @default.
- W4387305236 cites W2055654542 @default.
- W4387305236 cites W2080470132 @default.
- W4387305236 cites W2101078720 @default.
- W4387305236 cites W2104916446 @default.
- W4387305236 cites W2111581388 @default.
- W4387305236 cites W2112872200 @default.
- W4387305236 cites W2124679671 @default.
- W4387305236 cites W2157888202 @default.
- W4387305236 cites W2158246040 @default.
- W4387305236 cites W2212438965 @default.
- W4387305236 cites W2279201083 @default.
- W4387305236 cites W2300193196 @default.
- W4387305236 cites W2345592980 @default.
- W4387305236 cites W2346299551 @default.
- W4387305236 cites W2578119541 @default.
- W4387305236 cites W2593436234 @default.
- W4387305236 cites W2598719015 @default.
- W4387305236 cites W2770427050 @default.
- W4387305236 cites W2780742200 @default.
- W4387305236 cites W2792332020 @default.
- W4387305236 cites W2891400143 @default.
- W4387305236 cites W2908975342 @default.
- W4387305236 cites W2910679390 @default.
- W4387305236 cites W2922240769 @default.
- W4387305236 cites W2926113363 @default.
- W4387305236 cites W2928348539 @default.
- W4387305236 cites W2928665623 @default.
- W4387305236 cites W2942650903 @default.
- W4387305236 cites W2944925875 @default.
- W4387305236 cites W2946412700 @default.
- W4387305236 cites W2954747719 @default.
- W4387305236 cites W2969443468 @default.
- W4387305236 cites W2970424014 @default.
- W4387305236 cites W2977897459 @default.
- W4387305236 cites W2983166786 @default.
- W4387305236 cites W3006698773 @default.
- W4387305236 cites W3019393659 @default.
- W4387305236 cites W3025365911 @default.
- W4387305236 cites W3080738419 @default.
- W4387305236 cites W3083640581 @default.
- W4387305236 cites W3092083190 @default.
- W4387305236 cites W3107527779 @default.
- W4387305236 cites W3135817634 @default.
- W4387305236 cites W3158848342 @default.
- W4387305236 cites W3190486173 @default.
- W4387305236 cites W3201297223 @default.
- W4387305236 cites W3208280508 @default.
- W4387305236 cites W3212218762 @default.
- W4387305236 cites W4200304198 @default.
- W4387305236 cites W4205121918 @default.
- W4387305236 cites W4211221406 @default.
- W4387305236 cites W4214860294 @default.
- W4387305236 cites W4221048540 @default.
- W4387305236 cites W4221054247 @default.
- W4387305236 cites W4223458674 @default.
- W4387305236 cites W4223533234 @default.
- W4387305236 cites W4233862044 @default.
- W4387305236 cites W4281670608 @default.
- W4387305236 cites W4283220985 @default.
- W4387305236 cites W4283385641 @default.
- W4387305236 cites W4285092826 @default.
- W4387305236 cites W4286268170 @default.
- W4387305236 cites W4294670872 @default.
- W4387305236 cites W4296826792 @default.
- W4387305236 cites W4297317418 @default.
- W4387305236 cites W4312066386 @default.
- W4387305236 doi "https://doi.org/10.3389/fphar.2023.1242194" @default.
- W4387305236 hasPublicationYear "2023" @default.
- W4387305236 type Work @default.
- W4387305236 citedByCount "0" @default.
- W4387305236 crossrefType "journal-article" @default.
- W4387305236 hasAuthorship W4387305236A5016184474 @default.
- W4387305236 hasAuthorship W4387305236A5041477172 @default.
- W4387305236 hasAuthorship W4387305236A5082340386 @default.
- W4387305236 hasAuthorship W4387305236A5087268228 @default.
- W4387305236 hasAuthorship W4387305236A5089217713 @default.
- W4387305236 hasAuthorship W4387305236A5091020799 @default.
- W4387305236 hasBestOaLocation W43873052361 @default.
- W4387305236 hasConcept C104317684 @default.
- W4387305236 hasConcept C126322002 @default.
- W4387305236 hasConcept C142724271 @default.
- W4387305236 hasConcept C150194340 @default.